Clinical trial
A Control-IQ Technology 2.0 Feasibility Study in Adult and Adolescent Subjects
NCT05014789 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Control-IQ Technology 2.0 Feasibility Study in Adult and Adolescent Subjects
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 19, 2021
- Completion date
- December 20, 2021
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.